In a liver cancer xenograft mouse model, the tumor volume in the hyperoside-treated group was significantly reduced, and its anti-tumor effect is closely linked to the inhibition of the PI3K/AKT signaling pathway and the regulation of apoptosis pathways (Jiang et al., 2018; Wei et al., 2021). This evidence concerns the gene AKT1 and neoplasm.